Serum YKL-40 as a biomarker for liver fibrosis in chronic hepatitis B patients with normal and mildly elevated ALT.
about
Serum YKL-40 as a biomarker for liver fibrosis in chronic hepatitis B patients with normal and mildly elevated ALT.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Serum YKL-40 as a biomarker fo ...... ormal and mildly elevated ALT.
@en
Serum YKL-40 as a biomarker fo ...... ormal and mildly elevated ALT.
@nl
type
label
Serum YKL-40 as a biomarker fo ...... ormal and mildly elevated ALT.
@en
Serum YKL-40 as a biomarker fo ...... ormal and mildly elevated ALT.
@nl
prefLabel
Serum YKL-40 as a biomarker fo ...... ormal and mildly elevated ALT.
@en
Serum YKL-40 as a biomarker fo ...... ormal and mildly elevated ALT.
@nl
P2093
P2860
P1433
P1476
Serum YKL-40 as a biomarker fo ...... normal and mildly elevated ALT
@en
P2093
China HepB-Related Fibrosis Assessment Research Group
Guiqiang Wang
Linlin Yan
Yongqiong Deng
P2860
P2888
P304
P356
10.1007/S15010-018-1136-2
P50
P577
2018-03-29T00:00:00Z